|
Tuesday, March 9 — 8:00 AM — Ballroom B
Click on the numbers in parentheses to display abstracts.
Section B - HEMATOPATHOLOGY
Chaired by: Yaso Natkunam and Peter Banks
| 8:00 |
JAK3 Activation Is Significantly Associated with ALK Expression in Anaplastic Large Cell Lymphoma
(1001)
HM Amin, R Lai, Q Lin, M Feretzaki, I Grammatikakis, LJ Medeiros, GZ Rassidakis - The University of Texas MD Anderson Cancer Center, Houston, TX
|
| 8:15 |
Distinct Patterns of TRAF-1 Expression and c-rel Activation in Nodular Sclerosis Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma
(1122)
SJ Rodig, KJ Savage, GS Pinkus, MA Shipp, JC Aster, JL Kutok - Brigham and Women's Hospital, Boston, MA; Dana Farber Cancer Institute, Boston, MA
|
| 8:30 |
Natural History of Angioimmunoblastic T-Cell Lymphoma in Sequential Biopsies
(1005)
AD Attygalle, TC Diss, CM Bacon, L Baginsky, PG Isaacson, MQ Du, A Dogan - University College London; University of Cambridge, United Kingdom
|
| 8:45 |
Immunohistochemical Characterization of Nasal Type Extranodal NK/T Cell Lymphoma and Related Entities Using a Tissue Microarray: An Analysis of 96 Cases
(1131)
EJ Schwartz, H Molina-Kirsch, S Zhao, RA Warnke, Y Natkunam - Stanford University School of Medicine, Stanford, CA; San Juan General Hospital, Guatemala City, Guatemala
|
| 9:00 |
Methylation Profiles of Nasal NK/T Cell Lymphoma and Adult T-Cell Leukemia/Lymphoma
(1066)
S Ishizawa, T Hayashi, K Gaal, LM Weiss, DA Arber - City of Hope National Medical Center, Duarte, CA; Toyama Medical and Pharmaceutical University Hospital, Toyama, Japan; Nagasaki University Hospital, Nagasaki, Japan; Stanford University Medical Center, Stanford, CA
|
| 9:15 |
Bcl-2 Expression but Not p53 or p21 Is a Prognostic Marker in Classical Hodgkin Lymphoma: A Tissue Microarray Study
(1145)
SJ Sup, C Alemany, B Pohlman, S Malhi, S Thakkar, R Steinle, ED Hsi - Cleveland Clinic Foundation, Cleveland, OH
|
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION III
|
| 11:00 |
MALT Lymphoma with t(14;18)(q32;q21) Is Characterized by Strong Cytoplasmic MALT1 and BCL10 Expression
(1082)
H Liu, H Ye, S Shirali, L Gong, A Chott, B Streubel, R Siebert, S Gesk, JA Radford, S Banerjee, PG Isaacson, A Dogan, M-Q Du - University of Cambridge, Cambridge, United Kingdom; University of Vienna, Vienna, Austria; University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany; Cancer Research UK, Christie Hospital, Manchester, United Kingdom; University College London, London, United Kingdom
|
| 11:15 |
Extranodal Marginal Zone B-Cell Lymphomas of Mucosa Associated Lymphoid Tissue (MALT lymphomas) Contain Heterogeneous Chromosome Translocations That Result in Fusion of API2-MALT1, IGH-MALT1, IGH-BCL10, and IGH-BCL6, as Well as Translocations Involving IGH and Other Partner Genes
(1120)
ED Remstein, PJ Kurtin, RR Einerson, SF Paternoster, SR Brockman, GW Dewald - Mayo Clinic, Rochester, MN
|
| 11:30 |
Aberrant BCL6 Protein Expression in Mantle B-Cell Lymphomas
(1017)
FI Camacho, JF Garcia, JC Cigudosa, E Ruiz-Ballesteros, N Martinez, L Sanchez-Verde, P Gonzalvo, C Perez-Seoane, M Mollejo, MA Piris - Centro Nacional de Investigaciones Oncologicas
(CNIO), Madrid, Spain; Complejo Hospitalario de Toledo, Toledo, Spain; Hospital Comarcal de Jarrio, CoaZa-Asturias, Spain; Hospital Reina Sofia, Cordoba, Spain
|
| 11:45 |
Sinus Histiocytosis with Massive Lymphadenopathy in Patients with Autoimmune Lymphoproliferative Syndrome
(1087)
I Maric, S Pittaluga, J Dale, SE Straus, ES Jaffe - NCI, Bethesda, MD; NIAID, Bethesda, MD
|
|
|
